Article metrics

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

 

Online download statistics by month:

Online download statistics by month: May 2021 to May 2024

AbstractFullPdf
May 202111251106418
Jun 2021684678166
Jul 2021368364131
Aug 2021863856250
Sep 2021432430207
Oct 2021356353173
Nov 2021211207102
Dec 202117317259
Jan 202221822872
Feb 202224824980
Mar 202293794072
Apr 202296797880
May 202295695677
Jun 202290991757
Jul 202231531557
Aug 202218821188
Sep 202216116247
Oct 202216417359
Nov 202219720072
Dec 202213813644
Jan 202316416451
Feb 202324424172
Mar 202327426270
Apr 202319719273
May 202318318252
Jun 202318317651
Jul 202317516738
Aug 202317517654
Sep 202315915842
Oct 202324022966
Nov 202337837440
Dec 202325724564
Jan 202413112356
Feb 202417817564
Mar 2024288285143
Apr 202426526380
May 202420420367
Total13305132463394